Cecilia H. Fu

Cecilia H. Fu is a Clinical Associate Professor of Pediatrics specializing in pediatric oncology and hematology. Her research focuses on understanding genetic and environmental risk factors for childhood leukemias, optimizing therapeutic regimens for relapsed hematologic malignancies, and improving clinical trial accessibility for linguistically diverse populations. She leads studies on pediatric leukemia genomics, drug efficacy in relapsed ALL, and the role of obesity in treatment outcomes.

Her work bridges clinical practice and translational research, with a strong emphasis on translational studies of genetic polymorphisms (e.g., BMI1, CDKN2A), drug metabolism, and novel combination therapies (e.g., BDMV regimen). She has contributed to international trials through the Children’s Oncology Group, investigating treatment protocols for acute promyelocytic leukemia and chronic myeloid leukemia.

Key research themes include: (1) identifying genetic markers predictive of leukemia risk and treatment response, (2) evaluating lifestyle factors (maternal diet, obesity) influencing disease progression, and (3) developing culturally competent clinical trial recruitment strategies. Her studies often integrate genomic analysis with clinical outcomes to improve pediatric cancer care.